A NEW APPROACH TO THE DEVELOPMENT OF ANTI-CANCER AGENTS-5-FU DERIVATIVES.OKADA T; NAKAYAMA M; MITSUI R et al.1974; HIROSHIMA J. MED. SCI.; JAP.; DA. 1974; VOL. 23; NO 2-3; PP. 51-76; BIBL. 19 REF.Article

Increased levels of thymidylate synthetase in cells exposed to 5-fluorouacilWASHTIEN, W. L.Molecular pharmacology. 1984, Vol 25, Num 1, pp 171-177, issn 0026-895XArticle

ANTITUMOR ACTIVITY OF BENZOYL AND BENZENESULFONYL DERIVATIVES OF 5-FLUOROURACILHOSHI A; IIGO M; NAKAMURA N et al.1974; GANN; JAP.; DA. 1974; VOL. 65; NO 5; PP. 463Article

USE OF FLUOROURACIL-URACIL COMBINATIONS TO STUDY GROWTH ACCOMPANIED BY INSUFFICIENT DEOXYRIBONUCLEIC ACID SYNTHESIS IN BACILLUS CEREUSDOOLITTLE CH; MANDEL HG; HAHN GA et al.1973; J. BACTERIOL.; U.S.A.; DA. 1973; VOL. 113; NO 3; PP. 1311-1319; BIBL. 26REF.Serial Issue

Maculopapular eruption resulting from systemic administration of 5-fluorouracilREED, W. P; MORRIS, D. M.Cutis (New York, NY). 1984, Vol 33, Num 4, pp 381-382, issn 0011-4162Article

REVERSED-PHASE LIQUID CHROMATOGRAPHY OF 5-FLUORO-URACIL NUCLEOSIDES AND NUCLEOTIDES IN THE PRESENCE OF QUATERNARY AMMONIUM IONSGELIJKENS CF; DE LEENHEER AP.1980; J. CHROMATOGR.; NLD; DA. 1980; VOL. 194; NO 3; PP. 305-314; BIBL. 39 REF.Article

PARTIAL PROTECTION OF THE GASTRIC TOXICITY OF REGIONAL 5-FLUOROURACIL INFUSION BY THYMIDINE AND CIMETIDINEAL JURF AS.1982; J. SURG. ONCOL.; ISSN 0022-4790; USA; DA. 1982; VOL. 20; NO 3; PP. 179-181; BIBL. 15 REF.Article

Assay for pyrimidine nucleoside phosphorylases in tissue extracts by high-performance liquid chromatographyKONO, A; SUGATA, S; HARA, Y et al.Chemical and pharmaceutical bulletin. 1983, Vol 31, Num 5, pp 1666-1669, issn 0009-2363Article

THE ASSESSMENT OF RESPONSE OF MURINE TRANSPLANTABLE COLON TUMORS TO COMBINATION CHEMOTHERAPYCOWEN DM; SIEGERSTETTER J; JANIK AC et al.1982; JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; ISSN 0171-5216; DEU; DA. 1982; VOL. 103; NO 2; PP. 119-126; BIBL. 9 REF.Article

5-FLUOROURACIL AND DERIVATIVES IN CANCER CHEMOTHERAPY. II. POSSIBLE IN VIVO FORMATION AND STABILIZATION OF 5-FLUORO-2-DEOXYURIDINE = LE FLUORO-5 URACILE ET SES DERIVES EN CHIMIOTHERAPIE ANTICANCEREUSE. II. FORMATION POSSIBLE IN VIVO ET STABILISATION DE FLUORO-5 DESOXY-2 URIDINEWINDHEUSER JJ; JATO J.1972; J. PHARM. SCI.; U.S.A.; DA. 1972; VOL. 61; NO 10; PP. 1669-1670; BIBL. 9REF.Serial Issue

CHEMOTHERAPEUTIC STUDY ON YOSHIDA SARCOMA ASCITES CELLS IMPLANTED INTO THE GLANDULAR STOMACH OF RATS: MONOTHERAPY WITH 5-FLUOROURACIL, METHYL-CCNU, MITOMYCIN C, ADRIAMYCIN, AND CYTOSINE ARABINOSIDE, AND COMBINATION THERAPY WITH RESPECTIVE TWO-DRUG COMBINATIONSEICHLER G; HABS M; SCHMAEHL D et al.1983; JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; ISSN 0171-5216; DEU; DA. 1983; VOL. 105; NO 3; PP. 250-257; BIBL. 21 REF.Article

EFFET DIFFERENTIEL D'UNE IRRADIATION FRACTIONNEE ET DE L'ADMINISTRATION DE FLUORO-S URACILE SUR UNE TUMEUR MAMMAIRE CHEZ LA SOURIS BALB/C/CN^BMAISIN H; ANCKAERT MA; DECOSTER B et al.1983; COMPTES RENDUS DES SEANCES DE LA SOCIETE DE BIOLOGIE ET DE SES FILIALES; ISSN 0037-9026; FRA; DA. 1983; VOL. 177; NO 1; PP. 116-119; ABS. ENG; BIBL. 7 REF.Article

2.107.933 (B) (7134248). - 23SEPTEMBRE 1971. PROCEDE DE PREPARATION DU FLUORO-5 URACILEsdPatent

TWO MECHANISMS OF INTERFERON PRODUCTION BY LEUKOCYTES FROM IMMUNIZED ANIMALS = DEUX MECANISMES DE PRODUCTION D'INTERFERON PAR DES LEUCOCYTES D'ANIMAUX IMMUNISESTRUBINA LM; YAKOVENKO ZF; ZAKHARCHENKO EM et al.1975; ACTA VIROL.; TCHECOSL.; DA. 1975; VOL. 19; NO 2; PP. 116-120; BIBL. 10REF.Article

ADJUVANT THERAPY OF GASTRO-INTESTINAL CANCERSCHEIN PS; COOMBES RC.1982; DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH; ISSN 0378-6501; CHE; DA. 1982; VOL. 8; NO 4; PP. 427-433; BIBL. 30 REF.Article

THE SYNTHESIS OF ¹⁸F-5-FLUOROURACIL. VII1973; J. NUCL. MED.; U.S.A.; DA. 1973; VOL. 14; NO 1; PP. 63-64; BIBL. 11 REF.Serial Issue

Tamoxifen and 5-fluorouracil in breast cancer: cytotoxic synergism in vitro = Le tamoxifène et le 5-fluorouracile dans le cancer du sein: synergie cytotoxique in vitroBENZ, C; CADMAN, E; GWIN, J et al.Cancer research (Baltimore). 1983, Vol 43, Num 11, pp 5298-5303, issn 0008-5472Article

Combined cytotoxic effect of low-dose 5-fluorouraciland hydroxyurea on 9L cells in vitro = Effets cytotoxiques combinés du 5-fluorouracile à faible dose et de l'hydroxyurée sur les cellules 9L in vitroKOBAYASHI, S; HOSHINO, T.Cancer research (Baltimore). 1983, Vol 43, Num 11, pp 5309-5313, issn 0008-5472Article

RAPID CATABOLISM OF 5-FLUOROURACIL IN FRESHLY ISOLATED RAT HEPATOCYTES AS ANALYZED BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHYSOMMADOSSI JP; GEWIRTZ DA; DIASIO RB et al.1982; J. BIOL. CHEM.; ISSN 0021-9258; USA; DA. 1982; VOL. 257; NO 14; PP. 8171-8176; BIBL. 35 REF.Article

DIE ISOLIERTE LEBERPERFUSION MIT 5-FLUOROURACIL(5-FU) BEIM MENSCHEN = LA PERFUSION DU FOIE ISOLEE PAR LE 5-FLUOROURACILE CHEZ L'HOMMEAIGNER K; WALTHER H; TONN JC et al.1982; CHIRURG; ISSN 0009-4722; DEU; DA. 1982; VOL. 53; NO 9; PP. 571-573; ABS. ENG; BIBL. 9 REF.Article

Pharmacokinetic rationale for the interaction of 5-fluorouracil and misonidazole in humans = Bases pharmacocinétiques de l'interaction entre 5FU et misonidazole chez l'hommeMCDERMOTT, B. J; VAN DEN BERG, H. W; MARTIN, W. M. C et al.British journal of cancer. 1983, Vol 48, Num 5, pp 705-710, issn 0007-0920Article

METABOLIC FATE OF 1-HEXYLCARBAMOYL-5-FLUOROURACIL AND 5-FLUOROURACIL IN MICE BEARING ASCITES SARCOMA 180IIGO M; KURETANI K; HOSHI A et al.1981; J. NATL. CANCER INST.; ISSN 0027-8874; USA; DA. 1981; VOL. 66; NO 2; PP. 345-349; BIBL. 13 REF.Article

THE DIFFERENTIAL EFFECTS OF TWO SALTS OF 5-FLUOROURACIL AND OF DIETARY RESTRICTION ON ABSORPTION BY RAT SMALL INTESTINEGARDNER MLG; PLUMB JA.1981; BIOCHEM. PHARMACOL.; ISSN 0006-2952; GBR; DA. 1981; VOL. 30; NO 3; PP. 201-207; BIBL. 29 REF.Article

PHARMACOKINETICS OF 5-FLUOROURACIL: INTER-RELATIONSHIP WITH BIOCHEMICAL KINETICS IN MONITORING THERAPY.SADEE W; WONG CG.1977; CLIN. PHARMACOKINET.; NETHERL.; DA. 1977; VOL. 2; NO 6; PP. 437-450; BIBL. 2 P. 1/2Article

5-Fluorouracil reduces biofilm formation in Escherichia coli K-12 through global regulator AriR as an antivirulence compoundATTILA, Can; UEDA, Akihiro; WOOD, Thomas K et al.Applied microbiology and biotechnology. 2009, Vol 82, Num 3, pp 525-533, issn 0175-7598, 9 p.Article